IP Due Diligence for Israeli Startups (2026): What Investors and Founders Must Check

IP due diligence Israel is now the single most consequential workstream in any startup financing or exit, and the deals that fall apart in 2026 overwhelmingly do so because intellectual property ownership, chain of title or licence exposure was not verified early enough. This guide is a practical, Israel-specific playbook for founders, in-house counsel, investors and M&A lawyers preparing for a financing round or a trade sale. It tells you exactly what to collect, how to verify it, when a defect is fatal versus fixable, and how to price, escrow or remediate the risk. Read on for step-by-step checks, sample protective clauses and a clear decision framework.

This guidance is general and is not a substitute for legal advice. Verify every statutory reference and procedural step against current Israeli law before relying on it in a transaction.

TL;DR, The seven must-do checks before any term sheet

If you only do seven things before opening a data room, do these:

• Confirm chain of title. Every patent, application and material copyright must trace cleanly from inventor or author to the company via signed assignments.
• Verify inventor and employee assignments. Check that every current and former employee and contractor signed an assignment-of-inventions and confidentiality agreement.
• Search the public registers. Confirm registrations, recorded assignments, liens and security interests at the Israel Patent Office (which administers patents, trademarks and designs).
• Audit inbound licences and open source. Map every third-party licence and open source component, and flag copyleft exposure.
• Assess patentability and validity risk. Scrutinise software and life-science claims for enforceability weaknesses.
• Review trade-secret hygiene. Confirm there are written policies, access controls and documented classification.
• Build the remediation and warranty package. Decide what to fix before close and what to cover with reps, escrow or insurance.

Intended readers: founders, in-house counsel, investors and M&A lawyers preparing for financing or exit. Use this guide to decide whether to remediate before closing, purchase insurance, or negotiate price and escrows.

Why IP due diligence Israel matters in 2026

Israel’s startup economy is built on intangible assets, and investors have sharpened their scrutiny accordingly. In recent years, the dominant investor focuses have been chain of title, software patentability boundaries and demonstrable trade-secret hygiene. A company can have an impressive patent portfolio on paper, but if the underlying inventions were never properly assigned to the company, the portfolio is an illusion, and the acquirer or investor is buying litigation, not rights.

The statutory backbone matters here. Patent rights, ownership and the recording of assignments are governed by Israel’s Patents Law, 5727-1967. Trade secrets are protected under the Commercial Wrongs Law, 5759-1999 (also translated as the Commercial Torts Law), which sets the standard for what qualifies as a protectable secret and the remedies available for misappropriation. Understanding these frameworks is what separates a superficial review from genuine IP due diligence Israel work that stands up in a negotiation.

Consider a common, anonymised failure pattern seen in Israeli deals: a founding engineer develops the core algorithm before formally joining the company, or while moonlighting, and never signs a clean assignment. Years later, during exit diligence, the acquirer discovers the company may not own its crown-jewel technology. The Israeli courts have repeatedly adjudicated inventor-assignment and ownership disputes, including questions of service inventions, and published decisions are accessible through the Judiciary of Israel court portal. The lesson is consistent: undocumented ownership is the defect that most often triggers a price cut, an escrow, or a walk.

Because software claims and their enforceability attract particular attention, and because trade-secret proof depends on contemporaneous documentation, effective IP due diligence Israel in 2026 is as much about evidence as it is about registration certificates.

Quick checklist, what startups must disclose to investors

Investors expect a complete, honest disclosure schedule. Incomplete disclosure is itself a red flag and often a breach of warranty later. The question “What IP should a startup disclose to investors in Israel?” has a definitive answer.

Minimum disclosure list

• IP register. All registered patents, trademarks and registered designs, plus the full status of every pending application (including PCT and national-phase filings).
• Assignments. Every inventor, employee and contractor assignment, and every corporate assignment in the chain of title.
• Licences. All inbound and outbound licences, sublicences and field-of-use or territorial restrictions.
• Open source and third-party code. A software bill of materials identifying every open source component and its licence.
• Encumbrances. Any security interests, liens, charges or pledges recorded against IP assets.
• Litigation and disputes. Current, threatened or past IP litigation, oppositions, cease-and-desist correspondence and ownership disputes.
• Government funding conditions. Any IP subject to grants or support from the Israel Innovation Authority, which can carry know-how transfer and manufacturing restrictions.
• Embargoed or restricted code. Any code subject to escrow or export restrictions.
• Internal policies. Trade-secret, confidentiality and invention-assignment policies, plus evidence they are enforced.

Disclosing early and completely is the founder’s strongest leverage: it narrows the scope of warranties investors demand and reduces the size of any escrow. Thorough IP due diligence Israel preparation on the sell side almost always produces better deal terms.

Patent due diligence Israel, what to check, documents and remediation

Patents are usually the highest-value and highest-risk category in a technology deal. Patent due diligence Israel work breaks into four verification streams: scope, title, encumbrances and validity.

Patent family and scope

Start by collecting the full patent estate. Request:

• Granted patents and their certificates, with claim sets.
• Pending applications, including provisional, PCT and national-phase filings.
• Prosecution histories (file wrappers) for each key application, which reveal narrowing amendments and examiner objections.
• Records of any Patent Prosecution Highway (PPH) requests and their outcomes.
• Maintenance and renewal fee records to confirm nothing has lapsed.

Scope matters commercially because a patent with claims narrowed heavily during prosecution may not cover the product the company actually sells. Read the claims against the product, not the marketing deck.

Chain of title and assignments

This is where most deals get stuck. The question “How do you check patent ownership and chain of title in Israel?” demands a disciplined, step-by-step verification:

1. Identify every named inventor on every patent and application.
2. Match each inventor to a signed assignment of inventions in favour of the company, checking the signing date against the invention date and the person’s employment or engagement status.
3. Obtain inventor declarations where required and confirm they are signed and complete.
4. Verify the corporate chain: if IP passed through a predecessor entity, a founder’s personal holding, or a reorganisation, confirm each transfer is documented.
5. Search the Israel Patent Office register to confirm that assignments have been recorded so the public register reflects the company as owner.
6. Reconcile board minutes and resolutions that authorised relevant filings or transfers.

Be alert to the “service invention” rules under the Patents Law: inventions made by an employee in consequence of and during the period of employment belong to the employer absent agreement otherwise, but questions of remuneration can arise before the Compensation and Royalties Committee. Clear contractual assignment and waiver language reduces this exposure.

Recording assignments at the Israel Patent Office is what updates the public register and provides third parties with notice of ownership. An unrecorded assignment can leave the company’s title vulnerable and is a frequent diligence finding.

Remediation: missing or defective assignments can often be cured by obtaining retroactive, confirmatory assignment statements from the inventors, recording previously executed but unrecorded assignments, and, where an employee or founder has left on bad terms, negotiating a remedial agreement. The earlier this is done, the cheaper it is; after a dispute arises, leverage and cost both move against the company.

Litigation and encumbrances

Confirm whether any patent is subject to a security interest, licence or charge. Check the Israel Patent Office register for recorded liens and licences, and cross-reference the company’s charge filings at the Corporations Authority. A pledged patent securing a loan, or an exclusive licence granted to a third party, can dramatically reduce the value of what the investor thinks they are acquiring. Review the court portal for any pending enforcement or ownership litigation.

Patentability risk for software and life-science claims

Software-implemented inventions attract close validity scrutiny in Israel, as elsewhere. The Patents Law framework governs patentable subject matter, and claims directed to abstract methods without a concrete technical contribution are more vulnerable to invalidity challenges. Red flags include:

• Claims drafted as pure business methods or mental processes dressed up in generic computing language.
• Life-science claims that may face utility, enablement or subject-matter objections.
• Core technology protected only by a single narrow patent with no fallback continuations.

Where validity risk is material, the practical response in IP due diligence Israel is to commission a focused validity assessment, consider trade-secret protection for the most sensitive elements, and reflect the residual risk in the deal’s warranties and price.

Trademark due diligence Israel, ownership, use, clearance and enforcement risk

Brand value can be as important as technology, especially for consumer and SaaS businesses approaching exit. Trademark due diligence Israel focuses on ownership, genuine use and conflict risk. Trademarks are governed principally by the Trade Marks Ordinance [New Version], 5732-1972.

Ownership and registration checks

Collect all registration certificates and confirm the registered owner is the company, not a founder, a predecessor entity, or an overseas affiliate. Check the Israel Patent Office trademark register for the status of each mark, any pending oppositions, and recorded assignments. As with patents, an assignment that was executed but never recorded leaves a gap on the public register that must be closed before close.

Use evidence and bad-faith risks

A registration is only as strong as the use behind it. Gather evidence of first use and continuous, genuine use in the relevant classes and territories. Registrations that have not been used may be exposed to cancellation for non-use, and marks registered in bad faith, for example, pre-emptively registering a name the company never intended to use commercially, can be challenged. Document the use trail now, while witnesses and records are available.

Clearing a brand for exit versus launch

Clearance for an exit is more rigorous than clearance for a product launch, because the acquirer inherits every latent conflict. Search for identical and confusingly similar marks, including transliterations between Hebrew, English and Arabic scripts, which are a distinctive feature of brand clearance in Israel. Where a conflicting mark exists, decide whether to secure a coexistence agreement, an assignment, or a rebrand before close.

Trademark schedule checklist: registered marks and classes; pending applications; recorded assignments; evidence of use; oppositions and disputes; domain names and social handles that support the brand. Deciding whether to require an assignment versus a licence of a founder-held mark is a core judgment in trademark due diligence Israel.

Trade secret due diligence, employment and inventor agreements to inspect and remediate

Trade secrets are protected under Israeli law only where the owner has taken reasonable measures to keep the information secret, under the Commercial Wrongs Law, 5759-1999. That means the diligence question is not just “what secrets exist?” but “can the company prove it protected them?” This is where “How should trade secrets and employee/inventor agreements be reviewed during due diligence?” becomes decisive.

Trade-secret hygiene

Inspect the practical measures:

• A written trade-secret and confidentiality policy, communicated to staff.
• Access controls that restrict sensitive information to those who need it.
• Classification and labelling of confidential materials.
• A maintained list or inventory of key trade secrets (source code, algorithms, formulations, customer data).
• Logs and audit trails demonstrating access is monitored.

If these measures are absent, the company may struggle to establish that the information qualifies as a protected trade secret, and remedies under the Commercial Wrongs Law may be harder to obtain.

Employee contracts and inventor declarations

Examine every employment agreement for a clear assignment of inventions to the company, a confidentiality undertaking, and reasonable post-termination obligations. Check scope carefully: does the assignment cover inventions made during employment and those using company resources? Confirm signing dates precede the relevant work. Non-compete restrictions in Israel are generally enforceable only within narrow limits and are frequently restricted by the labour courts, so do not rely on them as a substitute for proper assignment and confidentiality clauses. The question “What to look for in employee invention agreements?” reduces to clear assignment, defined scope, correct signing dates, and complete inventor declarations.

Contractors, outsourcers and third-party code

Freelancers and outsourced developers are a frequent chain-of-title gap. Without a written assignment, work produced by an independent contractor may not vest in the company by default. Confirm every contractor signed an NDA and an IP assignment, and map any third-party or open source code they introduced.

Remediation: roll out an updated confidentiality and assignment policy, obtain fresh assignment and improvement forms from anyone with a gap, segregate sensitive repositories, and, where misappropriation is suspected, consider seeking injunctive relief. Experienced Israeli IP counsel can support this work. Strong trade secret due diligence protects both value and enforceability.

Licences, open source and freedom to operate in Israel

Licensing and open source exposure can quietly undermine a deal. Licensing due diligence confirms the company actually has the rights it needs and has not taken on obligations it cannot meet.

Inbound licences and sublicences

Review every inbound licence for scope, territorial limits, field restrictions, assignability and change-of-control clauses. A licence that terminates on a change of control, or that cannot be assigned to an acquirer, is a classic deal complication, the technology the buyer wants may not transfer with the company. Confirm the company has the sublicensing rights its business model assumes.

Open source software

Build a software bill of materials and classify every open source component by licence type. Permissive licences are generally lower risk; copyleft licences can require disclosure of proprietary source code if components are combined or distributed in certain ways. Evidence of a compliance process, scanning tools, approval workflows, attribution records, is exactly what a sophisticated acquirer looks for. Undetected copyleft contamination in a core product is among the most serious findings in any IP due diligence Israel exercise.

Freedom to operate

A freedom to operate (FTO) analysis asks whether the company can sell its product without infringing third-party rights. Commission a formal FTO opinion when the product may practise broadly patented technology, when entering regulated sectors such as medtech or life sciences, or where inbound licences are complex. The answer to “When should an investor commission an FTO opinion in Israel?” is: whenever infringement exposure is plausible and the deal value justifies the cost.

Remediation: where a licence is a deal-breaker, options include re-licensing on acceptable terms, replacing the component, carving the asset out of the deal, or securing an indemnity from the sellers backed by escrow. Licensing due diligence done early gives you time to pursue the cheaper remedies.

Remediation, deal mechanics and sample protective clauses

Once diligence surfaces defects, the negotiation shifts to allocation of risk. The question “What clauses and warranties should be included in IP schedules for investment or exit deals?” is answered through a remedies ladder and a disciplined warranty package.

The remedies ladder

1. Fix before close. The cleanest outcome: record assignments, obtain confirmatory declarations, cure open source issues.
2. Escrow or holdback. Hold part of the consideration against defined IP risks, released on milestones or on the expiry of a survival period.
3. Representations and warranties insurance. Transfer residual risk to an insurer where the exposure is quantifiable.
4. Carve-outs and warranty caps. Exclude a problematic asset or limit liability where the risk cannot be fully resolved.

Sample protective items for term sheets and SPAs

The following are illustrative, seek counsel before drafting:

• Ownership and title reps. The company solely owns, or has valid rights to use, all IP needed for the business, free of liens.
• Assignment completeness. All employees, founders and contractors have validly assigned their inventions and, where applicable, waived moral rights.
• Validity and non-infringement. Registered IP is valid and subsisting, and the business does not infringe third-party rights.
• Licence and open source disclosure. All material licences and open source components are disclosed in the schedules, and the company complies with their terms.
• No undisclosed encumbrances. No security interests or third-party rights exist beyond those scheduled.
• Government funding. Any Israel Innovation Authority grants and their attendant obligations are disclosed.
• Survival and qualifiers. Set survival periods for IP warranties, with materiality and knowledge qualifiers negotiated deliberately.
• Source code escrow triggers. Define events, insolvency, failure to support, change of control, that release escrowed source code.
• Post-close covenants. Commit the sellers to complete any outstanding assignment recordings within a defined window after close.

In Israeli financings and exits, investors typically insist on robust ownership and assignment-completeness warranties, specific open source disclosure, and an escrow sized to the identified IP risk. Preparing these in advance is the payoff of thorough IP due diligence Israel.

Decision framework and side-by-side comparison for IP due diligence Israel

When a protectable asset exists, founders and investors must decide how to hold it: patent it, keep it as a trade secret, or licence and commercialise it. Take a position early, because the protection strategy drives the diligence scope and the remediation budget.

Our recommendation, stated plainly:

• Choose to patent when the invention is technical, the claims are likely to survive software scrutiny in Israel, and exclusivity delivers a measurable commercial advantage.
• Choose trade-secret protection when disclosure would destroy value, secrecy is realistically maintainable, and enforcement resources are limited.
• Choose to licence or assign when third-party platform dependency or your monetisation strategy requires broad commercial rights rather than defensive exclusivity.

Final checklist and next steps for founders and investors

Use this 12-point closing checklist, with indicative time and the owner responsible, to drive the transaction to close. Timeframes are estimates only and vary with deal complexity.

1. Complete IP register, about 1 week, founder counsel.
2. Chain-of-title verification, 2–4 weeks, founder counsel, reviewed by investor counsel.
3. Inventor and employee assignment audit, 2–3 weeks, founder counsel.
4. Record outstanding assignments at the Israel Patent Office, 2–4 weeks, specialist IP firm.
5. Register and lien searches, about 1 week, investor counsel.
6. Trademark ownership and use evidence, 2–6 weeks, founder counsel.
7. Trade-secret policy and access-control review, 2–4 weeks, founder counsel.
8. Open source bill of materials and compliance check, 2–4 weeks, specialist firm.
9. Inbound licence and change-of-control review, 1–2 weeks, investor counsel.
10. FTO assessment where warranted, 4–8 weeks, specialist IP firm.
11. Warranty, escrow and insurance package, negotiated in parallel, both counsel.
12. Remediation sign-off and disclosure schedules finalised, before signing, both counsel.

Done properly, IP due diligence Israel is not a compliance chore but a value driver: sellers who present clean title and documented protections close faster and at better terms, while investors who verify rigorously avoid buying someone else’s litigation. Start early, prioritise chain of title, and resolve the fixable defects before they become deal-breakers.

This guidance is general and is not a substitute for legal advice specific to your transaction.

Sources

1. Israel Patent Office (Ministry of Justice / gov.il)
2. The Judiciary of Israel, official courts portal
3. Israel Innovation Authority
4. WIPO Lex, Israel legislation (Patents Law, 5727-1967; Commercial Wrongs Law, 5759-1999; Trade Marks Ordinance)